Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.63 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9247859 | 0.98 | CRHBP (0.61) | CRHBPCRHR2GAAALDH1A1 | |
| Nitric Acid SCHEMBL8647053 | 0.94 | CRHBP (0.57) | CRHBPCRHR2GAAALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL9251412 | 0.85 | CRHBP (0.49) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL25475858 | 0.83 | CRHBP (0.50) | CRHBPCRHR2GAA | |
| SCHEMBL3476909 | 0.76 | CRHBP (0.38) | CRHBPCRHR2GAA | |
| SCHEMBL9921596 | 0.72 | GAA (0.38) | CRHBPCRHR2GAAALDH1A1 | |
| Hydrochloric Acid SCHEMBL3737938 | 0.71 | CRHBP (0.52) | CRHBPCRHR2 | |
| SCHEMBL3739463 | 0.70 | CRHBP (0.34) | CRHBPCRHR2ALDH1A1 | |
| SCHEMBL29265156 | 0.68 | CRHBP (0.34) | CRHBPCRHR2GAA | |
| SCHEMBL7248680 | 0.67 | GAA (0.33) | CRHBPCRHR2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2534131-B1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC (US) | 2014-03-19 | — | — | EP | claimed |
| US-8471041-B2 | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | ALLIANT TECHSYSTEMS INC. (US) | 2013-06-25 | — | — | US | claimed |
| EP-2534131-A1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC. (US) | 2012-12-19 | — | — | EP | claimed |
| US-8178698-B2 | Methods of synthesizing cyclic nitro compounds | ALLIANT TECHSYSTEMS INC. (US) | 2012-05-15 | — | — | US | claimed |
| WO-2011100090-A1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC. (US) | 2011-08-18 | — | — | WO | claimed |
| US-20110195947-A1 | METHODS OF SYNTHESIZING AND ISOLATING N-(BROMOACETYL)-3,3-DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME | ALLIANT TECHSYSTEMS INC. (US) | 2011-08-11 | — | — | US | claimed |
| US-20110130572-A1 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS | ALLIANT TECHSYSTEMS INC. (US) | 2011-06-02 | — | — | US | claimed |
| US-7745643-B2 | chemical synthesizing a N-(haloacetyl)-3,3-dinitro-azetidine compound; anticarciogenic, antiinflammatory, antihypoxic, antidiabetic agent; cardiovascular and autoimmune disease; rheumatoid arthritis, diabetic retinopathy | ALLIANT TECHSYSTEMS INC. (US) | 2010-06-29 | — | — | US | claimed |
| US-20090093644-A1 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS | ALLIANT TECHSYSTEMS INC. (US) | 2009-04-09 | — | — | US | claimed |
| US-5395945-A | Salt formation, neutralization | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1995-03-07 | — | — | US | claimed |
| US-5336784-A | Synthesis of 1,3,3-trinitroazetidine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-08-09 | — | — | US | claimed |
| US-20250049756-A1 | CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | NORTHROP GRUMMAN SYSTEMS CORP (US) | 2025-02-13 | — | — | US | disclosed |
| US-20240293360-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | EPICENTRX, INC. | 2024-09-05 | — | — | US | disclosed |
| CN-118561729-A | Synthetic method and application of nitro cyclic compound | 江南大学 | 2024-08-30 | — | — | CN | disclosed |
| EP-4351567-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | EpicentRx, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| US-5824806-A | Processes for preparing TNAZ | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE THE SECRETARY OF THE ARMY (US) | 1998-10-20 | — | — | US | disclosed |
| US-5808099-A | ADNAZ, compositions and processes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1998-09-15 | — | — | US | disclosed |
| US-5395945-A | Salt formation, neutralization | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1995-03-07 | — | — | US | disclosed |
| US-5395945-A | Salt formation, neutralization | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1995-03-07 | — | — | US | disclosed |
| US-5336784-A | Synthesis of 1,3,3-trinitroazetidine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293360-A1 | CRYSTALLINE ABDNAZ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | CRYZ, FASTKD5, DNAJA1 | CRHBP 2505/4885CRHR2 3999/4885GAA 2481/4885 |
| US-20110130572-A1 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS | NOS2, NOS1, NOS3 | CRHBP 4205/4885CRHR2 3653/4885GAA 3578/4885 |
| US-20090093644-A1 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS | NOS2, NOS1, NOS3 | CRHBP 4205/4885CRHR2 3653/4885GAA 3578/4885 |
| US-20250049756-A1 | CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | NOS1, NOS2, NOS3 | CRHBP 4430/4885CRHR2 3865/4885GAA 3166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.